The Mitochondrial Permeability Transition, Release of Cytochrome c and Cell Death

CORRELATION WITH THE DURATION OF PORE OPENINGS IN SITU*

Valeria PetronilliDagger §, Daniele PenzoDagger , Luca ScorranoDagger , Paolo BernardiDagger §, and Fabio Di Lisa§||

From the Consiglio Nazionale delle Ricerche Unit for the Study of Biomembranes at the Departments of Dagger  Biomedical Sciences and || Biological Chemistry, University of Padova, Viale Giuseppe Colombo 3, I-35100 Padova, Italy

Received for publication, November 26, 2000, and in revised form, December 26, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We investigated the relationship between opening of the permeability transition pore (PTP), mitochondrial depolarization, cytochrome c release, and occurrence of cell death in rat hepatoma MH1C1 cells. Treatment with arachidonic acid or A23187 induces PTP opening in situ with similar kinetics, as assessed by the calcein loading-Co2+ quenching technique (Petronilli, V., Miotto, G., Canton, M., Colonna, R., Bernardi, P., and Di Lisa, F. (1999) Biophys. J. 76, 725-734). Yet depolarization, as assessed from the changes of mitochondrial tetramethylrhodamine methyl ester (TMRM) fluorescence, is rapid and extensive with arachidonic acid and slow and partial with A23187. Cyclosporin A-inhibitable release of cytochrome c and cell death correlate with the changes of TMRM fluorescence but not with those of calcein fluorescence. Since pore opening must be accompanied by depolarization, we conclude that short PTP openings are detected only by trapped calcein and may have little impact on cell viability, while changes of TMRM distribution require longer PTP openings, which cause release of cytochrome c and may result in cell death. Modulation of the open time appears to be the key element in determining the outcome of stimuli that converge on the PTP.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

One of the key events in the course of apoptosis is the release of cytochrome c from mitochondria (1), which is able to activate procaspase 9 (2) and thus downstream caspases that amplify the death process (see Ref. 3 for review). Other mitochondrial proteins can be released as well, including apoptosis-inducing factor (4) and Smac/DIABLO, which promotes apoptosis by inactivating inhibitors of apoptosis proteins (5-7). Cytochrome c remains by far the most studied, and the mechanism(s) underlying its release are the matter of intense investigation and of considerable controversy.

Mitochondria from a variety of tissues can be induced to undergo an inner membrane permeability increase, the PT,1 which allows diffusion of solutes with molecular mass up to about 1,500 Da. It is widely accepted that this transition is mediated by opening of an inner membrane high conductance channel, the PTP (see Ref. 8 for a recent review). The PTP has been shown to be implicated in ischemic cell death through dysregulation of Ca2+ homeostasis and ATP depletion (9-11). Since the PT is accompanied by swelling as well as by cytochrome c release in vitro (12), it also represents an excellent candidate for the release of intermembrane proteins in the course of apoptosis as well (13, 14). An alternative mechanism for cytochrome c release is outer membrane insertion of truncated BID followed by oligomerization of BAX and/or BAK (15-18 and see Ref. 19 for review). However, it has been reported that insertion of BAX/BAK in the outer mitochondrial membrane can also cause cytochrome c release and cell death through a PT (20, 21), and BNIP3 (a BCL-2 family member) can cause a PT and cell death without release of cytochrome c and caspase activation (22). The mechanistic relationships between PT, cytochrome c release, and cell death remain therefore a matter of intense debate. It is conceivable that an overlap may exist between different mechanisms (which often are not mutually exclusive); but it should also be recognized that different pathways may be activated in different paradigms of cell death. Finally, apparent discrepancies may also arise from the interpretation of the results obtained with fluorescent probes (13) and from the fact that detection methods based on cell disruption can cause rather than measure cytochrome c release (23).

In this study we investigated the occurrence of cell death in rat hepatoma MH1C1 cells treated with AA, a potent PTP inducer that is characterized in the accompanying article (24), or with the ionophore A23187. We found that both treatments cause PTP opening in situ with similar kinetics, as assessed by the calcein loading-Co2+ quenching technique (25), while depolarization, as assessed from the fluorescence changes of the potentiometric probe TMRM, was rapid and extensive with AA and slow and partial with A23187. A parallel assessment of cell viability and of CsA-inhibitable cytochrome c release with a quantitative in situ method showed that cell death correlates with the TMRM rather than with the calcein fluorescence changes. Since pore opening must be accompanied by depolarization, these findings suggest that relatively short PTP openings are detected only by trapped calcein and have little impact on cell viability, while detectable changes of TMRM distribution require longer PTP openings, which eventually cause cytochrome c release and cell death. Thus, modulation of the open time appears to be the key element in determining the outcome of stimuli that impinge on the PTP.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Cultures-- MH1C1 rat hepatoma cells were seeded onto uncoated 22-mm (for calcein and annexin-V staining) or 13-mm (for immunofluorescence) diameter round glass coverslips and grown for 2 days in Ham's F-10 nutrient mixture supplemented with 10% fetal calf serum in a humidified atmosphere of 95% air, 5% CO2 at 37 °C in a Forma tissue culture water-jacketed incubator.

TMRM and Calcein Staining and Imaging-- MH1C1 cells were loaded with 10 nM TMRM and incubated as specified in the legend of Fig. 2. The extent of cell and hence mitochondrial loading with potentiometric probes is affected by the activity of the plasma membrane MDR P-glycoprotein, which is inhibited by CsA (13). Treatment with this drug therefore causes an increased mitochondrial fluorescence that can be erroneously interpreted as an increase of the mitochondrial membrane potential (see Ref. 13 for discussion). To prevent this artifact and to normalize the loading conditions, in all experiments with TMRM the medium was supplemented with 1.6 µM CsH, which inhibits the MDR pump (13), but not the PTP (26). MH1C1 cells were loaded with 1 µM calcein-acetomethoxy ester for 30 min at 37 °C in 1 ml of Hanks' balanced salt solution supplemented with 10 mM Hepes, pH 7.4, and 1 mM CoCl2 (25). Cells were then washed free of calcein and Co2+ and maintained in Hanks' balanced salt solution-Hepes. When specified, CsA was added to the cells after probe loading, and fluorescence acquisition was started 30 min later, a protocol that made addition of CsH unnecessary in the experiments with calcein (results not shown). Cellular fluorescence images were acquired with an Olympus IMT-2 inverted microscope, equipped with a xenon light source (75 watts) for epifluorescence illumination and with a 12-bit digital cooled CCD camera (Micromax, Princeton Instruments). For detection of fluorescence, 488 ± 25 nm excitation and 525 nm longpass emission and 568 ± 25 nm excitation and 585 nm longpass emission filter settings were used for calcein and TMRM, respectively. Images were collected with exposure times ranging between 50 and 100 ms using a 40×, 1.3 NA oil immersion objective (Nikon). Data were acquired and analyzed using Metamorph software (Universal Imaging). Clusters of several mitochondria (10 to 30) were identified as regions of interest, and fields not containing cells were taken as the background. Sequential digital images were acquired every 60 s or every 3 min for the experiments with a time course of 20 and 60 min, respectively, and the average fluorescence intensity of all relevant regions was recorded and stored for subsequent analysis. Mitochondrial fluorescence intensities minus background are reported in Figs. 2-4 after normalization of the initial fluorescence for comparative purposes, and they represent the mean of 10 regions of interest.

Immunodetection of bc1 Complex and Cytochrome c-- MH1C1 cells were incubated as detailed in the figure legends and then washed. Cells were fixed for 30 min at room temperature with 3.7% (v/v) ice-cold formaldehyde, permeabilized for 20 min with 0.01% (v/v) ice-cold Nonidet P-40, and incubated for 15 min with a 0.5% solution of BSA and then for 15 min at 37 °C with a mouse monoclonal anti-cytochrome c antibody (PharMingen, clone 6H2.B4) and with an affinity-purified rabbit antibody against the rat bc1 complex (a generous gift of Prof. Roberto Bisson, Padova, Italy). Cells were then sequentially incubated for 15 min at 37 °C with tetramethylrhodamine isothiocyanate-conjugated goat anti-mouse IgG and with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG.

For cytochrome c and bc1 complex detection, red and green channel images were acquired simultaneously using two separate color channels on the detector assembly of a Nikon Eclipse E600 microscope equipped with a Bio-Rad MRC-1024 laser scanning confocal imaging system and with 488/522 ± 25 nm bandpass and 568/605 nm longpass filter settings, and a 60×, 1.4 NA oil immersion objective (Nikon). Twenty randomly chosen fields in each coverslip were stored for subsequent analysis.

Fig. 1 shows an example of the quantitative analysis carried out on a control (panel A) and AA-treated MH1C1 cell (panel B). Using the Bio-Rad LaserSharp analysis program a set of lines was drawn across the cells (only two such lines are illustrated in panels A and B for the sake of clarity). Using the appropriate function of the analysis program, the fluorescence intensity of each pixel along the line in both the green and the red channel was measured, and panels A' and B' report the fluorescence intensity profiles along the lines drawn in panels A and B, respectively. The localization index is defined as the ratio of the S.D. of the fluorescence intensity divided by the total fluorescence for each channel: (S.D./Sigma )red/(S.D./Sigma )green. A punctate distribution results in a higher S.D., while normalization allows correction for different fluorescence intensities in the two channels. A localization index of 1 indicates that cytochrome c and the bc1 complex have the same distribution, which is expected in normal cells, while an index lower than 1 means that the distribution of cytochrome c is more homogeneous than that of the bc1 complex. In the example of Fig. 1 the localization index is 1 for the cell of panel A and 0.6 for the cell in panel B.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Immunofluorescence detection of the bc1 complex and cytochrome c: effects of arachidonic acid. MH1C1 cells were treated for 30 min with vehicle (ethanol: 0.02% v/v; panel A) or with 0.2 mM AA (panel B). Images were acquired with the confocal microscope after immunofluorescence labeling as described under "Materials and Methods." Secondary antibodies against the bc1 complex were fluoresceinated (green color in the images), while antibodies against cytochrome c were conjugated with tetramethylrhodamine isothyocyanate (red color in the images). Bar, 10 µm. The fluorescence intensity profiles reported in panels A' and B' correspond to the lines drawn in panels A and B, respectively; and green and red lines refer to the bc1 and cytochrome c profiles, respectively.

Annexin-V and propidium iodide staining and imaging were carried out exactly as described previously (27).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The experiments of Fig. 2, panel A, report the fluorescence changes of mitochondria loaded with calcein in the presence of Co2+ in intact cells, a method that allows detection of PTP openings in situ (25). Addition of AA resulted in a large decrease of calcein fluorescence that was due to PTP opening (panel A, squares), as indicated here by inhibition of the fluorescence changes by CsA (panel A, circles; see also Ref. 24). A similar experiment was carried out in cells loaded with TMRM, a probe that accumulates within polarized mitochondria wherefrom it is released upon depolarization (28). It can be seen (panel B) that the addition of AA was followed by a large, CsA-sensitive depolarization with the same time course as that displayed by the changes of calcein fluorescence (compare with panel A) and comparable in extent to that observed upon the addition of FCCP to CsA-treated cells (panel B) or to cells that had not been treated with AA (see Fig. 4, panel B). These results indicate that PTP opening by AA causes mitochondrial depolarization in situ, a finding that was also obtained in nominally Ca2+-free media (results not shown).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Changes of mitochondrial calcein and TMRM fluorescence intensities induced by arachidonic acid. MH1C1 cells were coloaded with calcein-AM and CoCl2 (panel A) or TMRM (panel B) as described under "Materials and Methods," and images were collected at 60-s intervals. In the experiments denoted by circles, cells had been treated with 2 µM CsA. Where indicated (arrows) 200 µM AA and 2 µM FCCP were added. The initial fluorescence intensities were normalized for comparative purposes, and values on the ordinate report the mean ± S.D. of four independent experiments. Within the time course of this experiment, no significant changes of mitochondrial calcein or TMRM fluorescence intensities were observed when cells were treated with vehicle (ethanol: 0.02%, v/v) or CsA in the absence of further additions (omitted for clarity).

A similar experiment was carried out with the divalent metal ionophore A23187. Fig. 3, panel A, shows that addition of A23187 caused a rapid drop of calcein fluorescence (squares), which was much faster than that caused by AA (compare with panel A in Fig. 2), and essentially complete within about 3 min of the addition of A23817. The fluorescence changes were still due to PTP opening, as indicated by their sensitivity to CsA (circles). Quite unexpectedly, however, the changes of TMRM fluorescence were negligible over the same time frame and slowly decreased by only 20% in about 20 min of incubation (panel B, squares). These TMRM fluorescence changes were also due to the PTP, since they could be blocked by CsA, which instead did not affect the probe response to FCCP (panel B, circles). These experiments demonstrate that PTP openings may occur that are accompanied by negligible changes of TMRM fluorescence and suggest that the time required for redistribution of potentiometric probes like TMRM may be too long (28) to report these PTP openings, which we assume to be of short duration. At variance from the case of AA, the PTP-inducing effects of A23187 disappeared in Ca2+-free media (results not shown).



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Changes of mitochondrial calcein and TMRM fluorescence intensities induced by A23187. Experimental conditions and symbols were exactly as in Fig. 2. Where indicated (arrows) 2 µM A23187 and 2 µM FCCP were added.

We next tested whether depolarization with the protonophore FCCP was able to cause PTP opening in MH1C1 cells in the absence of inducing agents like AA or A23187. The experiments of Fig. 4, panel A, indicate that no changes of calcein fluorescence could be elicited by FCCP either in the absence or presence of CsA (squares and circles, respectively) and that, consistently, the FCCP-dependent decrease of TMRM fluorescence was not affected by CsA (panel B, symbols are the same as in panel A). These experiments thus allowed to define three clear-cut conditions: (i) PTP openings matched by a measurable mitochondrial depolarization (addition of AA, Fig. 2); (ii) PTP openings not matched by a measurable mitochondrial depolarization (addition of A23187, Fig. 3); and (iii) mitochondrial depolarization without PTP opening (addition of FCCP, Fig. 4). The next question we addressed was whether any of these conditions was associated to release of mitochondrial cytochrome c and cell death.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Changes of mitochondrial calcein and TMRM fluorescence intensities induced by FCCP. Experimental conditions and symbols were exactly as in Fig. 2. Where indicated (arrows) 2 µM FCCP was added.

In the experiments of Fig. 5 the distribution of cytochrome c and of the mitochondrial bc1 complex were studied in individual cells in situ with the quantitative technique described under "Materials and Methods." It can be clearly appreciated that the addition of FCCP had negligible effects on the cytochrome c distribution (open triangles). On the other hand, within 30 min of the addition of A23187 the localization index decreased from 1.0 to 0.8 (open circles), a finding that closely matched the A23817-dependent fluorescence changes of TMRM but not those of calcein (compare with Fig. 3). Finally, the addition of AA caused a drop in the localization index of cytochrome c to 0.5 within 10 min (open squares), which matched most closely the kinetics of PTP-dependent changes of TMRM fluorescence (compare with Fig. 2). In these protocols cytochrome c redistribution was dependent on PTP opening, as shown by its almost complete inhibition by CsA (closed symbols in Fig. 5).



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of arachidonic acid, A23187, or FCCP treatment on the intracellular cytochrome c localization. MH1C1 cells were treated for the indicated times with 0.2 mM AA (squares), 2 µM A23187 (circles), 2 µM FCCP (triangles) or vehicle (0.02% v/v ethanol, diamonds). In the experiments denoted by solid symbols, cells were pretreated with 2 µM CsA for 15 min. Cells were fixed and treated with antibodies against the bc1 complex and cytochrome c, and the cytochrome c localization index was determined exactly as described under "Materials and Methods" and in the legend to Fig. 1. Values are mean ± S.D. of five different experiments. No significant changes of the localization index were observed when cells were treated with CsA in the absence of further additions (omitted for clarity).

We finally assessed the consequences of treatment with AA, A23187, and FCCP on cell viability by double staining with fluoresceinated annexin-V and propidium iodide. The experiments of Fig. 6 document that within 30 min of treatment with AA about 50% of the cells displayed an apoptotic phenotype (i.e. they were positive for Annexin-V only), while this figure was less than 30% after treatment with A23187 and negligible relative to control cells after treatment with FCCP, and CsA effectively prevented cell death by both AA and A23187. As the incubation proceeded, most AA-treated cells became permeable to propidium iodide (results not shown).



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of arachidonic acid, A23187, and FCCP on cells staining with annexin-V and propidium iodide. MH1C1 cells grown on coverslips were treated for 45 min with 0.2 mM AA, 2 µM A23187, 2 µM FCCP, or vehicle only (control, 0.02% v/v ethanol). When indicated cells were pretreated with 2 µM CsA for 15 min. Cells were stained with annexin-V-FLUOS and propidium iodide, and images of cells fields on coverslips were acquired with the epifluorescence microscope as described previously (27). The fraction of annexin-V-positive cells (filled bars) and double positive cells (hatched bars) was calculated from 20 randomly chosen fields from four independent experiments, and values are mean ± S.D.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Preliminary Considerations-- The PTP has been extensively characterized in mitochondrial suspensions (29-31), in individual organelles (32), and at the single channel level (33 and 34 and see Ref. 8 for a comprehensive review). Although its structural features are still a matter of debate (see e.g. Ref. 35), the functional properties of the PTP and the consequences of a PT in vitro are relatively well understood (8). Despite these advances, it remains extremely difficult to make predictions about the occurrence and regulation of the PT in situ, in part because the PTP is detected by indirect means, most often based on the expected changes of the mitochondrial membrane potential, and in part because multiple PTP modulatory factors change at the same time. A striking example is represented by the effects of FCCP. The pore is voltage-dependent, in the sense that depolarization favors PTP opening (36), yet the effect of depolarization may be offset by matrix acidification (37) and by the increase of matrix ADP and Mg2+, which all prevent pore opening. The experiments reported here indicate that depolarization with FCCP is not followed by PTP opening in MH1C1 cells, suggesting that PTP inhibitory factors prevail despite depolarization. Two main issues should be considered.

(i) The open-closed transitions of individual channels occur well below the time range of the msec (33), which imposes obvious constraints in measurements based on redistribution of potentiometric fluorescent probes in situ. Indeed, transient PTP openings may not be detected when the probe response time is below the PTP open time, implying that only relatively long lasting PTP openings may be reliably detected by these probes in situ. Furthermore, even TMRM-detectable PTP openings may occur asynchronously in individual mitochondria (32) and would be missed unless single mitochondria are resolved.

(ii) The cellular accumulation of potentiometric probes is not a simple function of the mitochondrial membrane potential. It also depends on net transport across the plasma membrane, which is determined by the plasma membrane potential (which drives the accumulation) and by the activity of the MDR pump (which extrudes the probe). Mitochondrial accumulation will be affected by changes of the plasma membrane potential (38, 39), and inhibition of the MDR pump will inevitably increase the mitochondrial probe accumulation (13). It is unfortunate that both the PTP and the MDR pump are inhibited by CsA (13), a finding that calls into question the interpretation of a large number of experiments where the PTP has been considered as a causative event in cell death (13).

Because of these problems, we have developed a method for in situ PTP detection that is based on trapping of calcein followed by quenching of cytosolic fluorescence by Co2+. Since calcein and Co2+ cannot cross the mitochondrial inner membrane, PTP opening can be studied as a CsA-sensitive quenching of mitochondrial calcein fluorescence (25). To address the second problem we have included CsH (which inhibits the MDR pump but not the PTP) in our measurements. Given that the MDR pump is already inhibited by CsH, the effects of CsA on the TMRM signal coming from mitochondria must be due to effects on the PTP. A contribution from variations of the plasma membrane potential cannot be excluded easily, yet this was not the major cause of the TMRM fluorescence changes in our protocols, because they were also observed in KCl-based media (results not shown).

PTP Opening and Cytochrome c Release-- Based on the results of the present paper, we conclude that the changes of calcein fluorescence are able to detect PTP openings of shorter duration than those detectable by TMRM. Indeed, addition of A23187 induced large CsA-sensitive fluorescence changes of calcein but not of TMRM (Fig. 3). Cytochrome c release correlated better with the decrease of mitochondrial TMRM fluorescence than with changes of calcein fluorescence, suggesting that only relatively long lasting pore openings eventually cause cytochrome c release. The mechanism through which PTP opening may cause cytochrome c release remains unsolved. One possibility is that osmotic swelling causes outer membrane rupture and release of other intermembrane proteins as well, such as Smac/DIABLO (5, 7) and AIF (40). Outer membrane rupture may not occur in all mitochondria at the same time, nor necessarily cause major structural damage. Indeed, Farber and co-workers (41) have shown that transient PTP openings in vitro are not followed by detectable swelling in saline media, yet cause CsA-sensitive cytochrome c release. This could occur through swelling-shrinkage cycles of individual mitochondria in a nonsynchronized fashion (41). It is noteworthy that even after PTP-dependent large amplitude swelling of the whole mitochondrial population pore closure was followed by shrinkage with full functional recovery provided that cytochrome c was added back (12). This finding indicates that no permanent damage to the inner membrane is caused by even long lasting PTP openings (12).

An alternative possibility is that subtle changes of matrix volume may make more cytochrome c available for selective release (13). Tomographic reconstruction of thick sections of mitochondria after high voltage electron microscopy has indeed revealed that the intercristal spaces, which contain cytochrome c, are pleiomorphic structures that communicate with the peripheral (intermembrane) space, and sometimes between themselves, through very narrow tubular regions (42). These findings are in good agreement with earlier work demonstrating that only 10-15% of cytochrome c is available for reduction by outer membrane NADH-cytochrome b5 reductase and that this fraction can be effectively increased by matrix swelling (43). If this compartmentation also occurs in vivo, the matrix/intercristal volume changes caused by a PT could be instrumental to make cytochrome c available for release.

In summary, the present results demonstrate that PTP opening can be a causative event in cytochrome c release in situ irrespective of whether the latter occurs through a selective pathway or because of outer membrane rupture. Further work will be required to define the relevance of this mechanism to endogenous signaling pathways of cell death.


    FOOTNOTES

* This work was supported by grants from the Consiglio Nazionale delle Ricerche, the Ministero per l'Università e la Ricerca Scientifica e Tecnologica "Il Mantenimento della Vitalità Miocardica a Discapito della Necrosi" (to F. D. L.), and "Bioenergetica e Trasporto di Membrana" (to P. B.), by Telethon-Italy Grant 1141 (to P. B.), and by the Armenise-Harvard foundation (to P. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence and reprints requests may be addressed. E-mail: petro@civ.bio.unipd.it; bernardi@civ.bio.unipd.it; dilisa@civ.bio.unipd.it.

Present address: Dept. of Pathology and Medicine, Harvard University Medical School, Dana-Farber Cancer Institute, SM758, One Jimmy Fund Way, Boston, MA 01225.

Published, JBC Papers in Press, December 27, 2000, DOI 10.1074/jbc.M010604200


    ABBREVIATIONS

The abbreviations used are: PT, permeability transition; PTP, permeability transition pore; AA, arachidonic acid; CsA and CsH, cyclosporin A and cyclosporin H, respectively; TMRM, tetramethylrhodamine methyl ester; FCCP, carbonyl cyanide p-trifluoromethoxyphenylhydrazone; MDR, multidrug resistance.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES


1. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Cell 86, 147-157[Medline] [Order article via Infotrieve]
2. Zou, H., Li, Y., Liu, X., and Wang, X. (1999) J. Biol. Chem. 274, 11549-11556[Abstract/Free Full Text]
3. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X. D. (1999) Annu. Rev. Cell Dev. Biol. 15, 269-290[CrossRef][Medline] [Order article via Infotrieve]
4. Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. (1996) J. Exp. Med. 184, 1331-1341[Abstract]
5. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000) Cell 102, 33-42[Medline] [Order article via Infotrieve]
6. Chai, J., Du, C., Kyin, S., Wang, X., and Shi, Y. (2000) Nature 406, 855-862[CrossRef][Medline] [Order article via Infotrieve]
7. Ekert, P. G., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., and Vaux, D. L. (2000) Cell 102, 43-53[Medline] [Order article via Infotrieve]
8. Bernardi, P. (1999) Physiol. Rev. 79, 1127-1155[Abstract/Free Full Text]
9. Duchen, M. R., McGuinness, O., Brown, L. A., and Crompton, M. (1993) Cardiovasc. Res. 27, 1790-1794[Medline] [Order article via Infotrieve]
10. Imberti, R., Nieminen, A. L., Herman, B., and Lemasters, J. J. (1993) J. Pharmacol. Exp. Ther. 265, 392-400[Abstract]
11. Pastorino, J. G., Snyder, J. W., Serroni, A., Hoek, J. B., and Farber, J. L. (1993) J. Biol. Chem. 268, 13791-13798[Abstract/Free Full Text]
12. Petronilli, V., Nicolli, A., Costantini, P., Colonna, R., and Bernardi, P. (1994) Biochim. Biophys. Acta 1187, 255-259[Medline] [Order article via Infotrieve]
13. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V., and Di Lisa, F. (1999) Eur. J. Biochem. 264, 687-701[Abstract/Free Full Text]
14. Kroemer, G., and Reed, J. C. (2000) Nat. Med. 6, 513-519[CrossRef][Medline] [Order article via Infotrieve]
15. Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., and Korsmeyer, S. J. (2000) Genes Dev. 14, 2060-2071[Abstract/Free Full Text]
16. Li, H., Zhu, H., Xu, C. J., and Yuan, J. (1998) Cell 94, 491-501[Medline] [Order article via Infotrieve]
17. Gross, A., Yin, X. M., Wang, K., Wei, M. C., Jockel, J., Milliman, C., Erdjument, B. H., Tempst, P., and Korsmeyer, S. J. (1999) J. Biol. Chem. 274, 1156-1163[Abstract/Free Full Text]
18. Eskes, R., Desagher, S., Antonsson, B., and Martinou, J. C. (2000) Mol. Cell. Biol. 20, 929-935[Abstract/Free Full Text]
19. Gross, A., and Korsmeyer, S. J. (1999) Genes Dev. 13, 1899-1911[Free Full Text]
20. Pastorino, J. G., Chen, S. T., Tafani, M., Snyder, J. W., and Farber, J. L. (1998) J. Biol. Chem. 273, 7770-7775[Abstract/Free Full Text]
21. Bradham, C. A., Qian, T., Streetz, K., Trautwein, C., Brenner, D. A., and Lemasters, J. J. (1998) Mol. Cell. Biol. 18, 6353-6364[Abstract/Free Full Text]
22. Vande Velde, C., Cizeau, J., Dubik, D., Alimonti, J., Brown, T., Israels, S., Hakem, R., and Greenberg, A. H. (2000) Mol. Cell. Biol. 20, 5454-5468[Abstract/Free Full Text]
23. Adachi, S., Gottlieb, R. A., and Babior, B. M. (1998) J. Biol. Chem. 273, 19892-19894[Abstract/Free Full Text]
24. Scorrano, L., Penzo, D., Petronilli, V., Pagano, F., and Bernardi, P. (2001) J. Biol. Chem. 276, 12035-12040[Abstract/Free Full Text]
25. Petronilli, V., Miotto, G., Canton, M., Colonna, R., Bernardi, P., and Di Lisa, F. (1999) Biophys. J. 76, 725-734[Abstract/Free Full Text]
26. Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., and Bernardi, P. (1996) J. Biol. Chem. 271, 2185-2192[Abstract/Free Full Text]
27. Scorrano, L., Petronilli, V., Di Lisa, F., and Bernardi, P. (1999) J. Biol. Chem. 274, 22581-22585[Abstract/Free Full Text]
28. Loew, L. M., Tuft, R. A., Carrington, W., and Fay, F. S. (1993) Biophys. J. 65, 2396-2407[Abstract]
29. Hunter, D. R., and Haworth, R. A. (1979) Arch. Biochem. Biophys. 195, 453-459[Medline] [Order article via Infotrieve]
30. Haworth, R. A., and Hunter, D. R. (1979) Arch. Biochem. Biophys. 195, 460-467[Medline] [Order article via Infotrieve]
31. Hunter, D. R., and Haworth, R. A. (1979) Arch. Biochem. Biophys. 195, 468-477[Medline] [Order article via Infotrieve]
32. Huser, J., Rechenmacher, C. E., and Blatter, L. A. (1998) Biophys. J. 74, 2129-2137[Abstract/Free Full Text]
33. Szabo, I., and Zoratti, M. (1991) J. Biol. Chem. 266, 3376-3379[Abstract/Free Full Text]
34. Szabo, I., and Zoratti, M. (1992) J. Bioenerg. Biomembr. 24, 111-117[Medline] [Order article via Infotrieve]
35. Fontaine, E., and Bernardi, P. (1999) J. Bioenerg. Biomembr. 31, 335-345[CrossRef][Medline] [Order article via Infotrieve]
36. Bernardi, P. (1992) J. Biol. Chem. 267, 8834-8839[Abstract/Free Full Text]
37. Bernardi, P., Vassanelli, S., Veronese, P., Colonna, R., Szabo, I., and Zoratti, M. (1992) J. Biol. Chem. 267, 2934-2939[Abstract/Free Full Text]
38. Rottenberg, H., and Wu, S. (1998) Biochim. Biophys. Acta 1404, 393-404[CrossRef][Medline] [Order article via Infotrieve]
39. Nicholls, D. G., and Ward, M. W. (2000) Trends Neurosci. 23, 166-174[CrossRef][Medline] [Order article via Infotrieve]
40. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. (1999) Nature 397, 441-446[CrossRef][Medline] [Order article via Infotrieve]
41. Pastorino, J. G., Tafani, M., Rothman, R. J., Marcineviciute, A., Hoek, J. B., and Farber, J. L. (1999) J. Biol. Chem. 274, 31734-31739[Abstract/Free Full Text]
42. Frey, T. G., and Mannella, C. A. (2000) Trends Biochem. Sci. 25, 319-324[CrossRef][Medline] [Order article via Infotrieve]
43. Bernardi, P., and Azzone, G. F. (1981) J. Biol. Chem. 256, 7187-7192[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.